Joint safety and neurologic events with subcutaneous tanezumab or oral nonsteroidal anti-inflammatory drugs in subgroups of patients with osteoarthritis from an 80-week phase 3 study
作者
David John Hunter,S. Radominski,S. Rodriguez Ulloa,I. Goranov,Goran Radunović,Chong Bum Chang,Glenn C. Pixton,A. Hickman,Robert J. Fountaine,M. Brown,Lars Viktrup,Christine R. West